LLY

Why It’s Time to Sell These 3 Hot Stocks

By Joel Baglole, InvestorPlace Contributor
Holding onto a stock too long can lead to an evaporation of profits. Better for investors to sell a little too early than a little too late.

The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’

By Alex Sirois, InvestorPlace Contributor
Investors curious to identify the next magnificent 7 stock should start here as the clues are fairly straightforward

3 Stocks to Buy for Retirees Looking to Beat Inflation

By Joel Baglole, InvestorPlace Contributor
Retired investors looking to weather the current market with above-average returns should buy these inflation-beating retirement stocks.

7 Biotech Stocks to Buy for Big-Time Gains

By Louis Navellier and the InvestorPlace Research Staff
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

The Importance of Brand Power: 3 Stocks to Consider

By Joel Baglole, InvestorPlace Contributor
Count on these companies, whose reputations and brands are growing, leading their popular brand stocks to new heights.

7 A-Rated Tech Stocks to Buy for November

By Louis Navellier and the InvestorPlace Research Staff
By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.

7 A-Rated Stocks to Buy in Q4

By Louis Navellier and the InvestorPlace Research Staff
Even if you don’t believe in Santa Claus, there’s plenty of reason to believe you can fill your stockings with A-rated stocks to buy this…

AI-Powered Investing: 3 Promising Stocks for 2024

By Will Ashworth, InvestorPlace Contributor
With the further commoditization of asset management, stock predictions by AI have become far more prevalent.

7 Healthcare Stocks That Can Cure a Lackluster Portfolio

By Joel Baglole, InvestorPlace Contributor
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.

The Next Trillion-Dollar Companies: 3 Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor
The spotlight is on these three next trillion-dollar companies expected to continue growing at a rapid pace.

7 Cutting-Edge Stocks That Could Change Humanity as We Know It

By Joel Baglole, InvestorPlace Contributor
Investors wanting exposure to companies whose technology is changing the world should consider these cutting-edge stocks.

7 Stocks to Buy With Your 2024 Social Security Increase

By Joel Baglole, InvestorPlace Contributor
While the Social Security increase can be used to help with everyday living expenses such as groceries, gasoline, and mortgage payments, it can also be used to invest. Specifically, retirees can use any surplus funds from their higher Social Security payouts to buy stocks.

3 Biotech Stocks Ready to Break Out in 2024

By John Blankenhorn, InvestorPlace Contributor
Still, many biotech stocks to buy are positioned well for the coming quarter and new year. These show amazing drug portfolios, promising growth potential, and world-class technology.

Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024

By Joel Baglole, InvestorPlace Contributor
However, pharmaceutical stocks can be expected to eventually rebound. The good news for investors is that many pharma stocks are on sale right now and can be purchased at rock bottom prices.

Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns

By John Blankenhorn, InvestorPlace Contributor
These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector.

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor
The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020. 

Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher

By Muslim Farooque, InvestorPlace Contributor
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.

David vs. Goliath: 3 Stocks Poised to Challenge the ‘Magnificent 7′

By Alex Sirois, InvestorPlace Contributor
These three stocks are legitimate challengers to the dominance of the Magnificent 7 stocks as we move toward the end of 2023.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.
Load More